MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from january
2026 inducement...
$2,082K
Net cash provided by
financing activities
$1,794K
Canceled cashflow
$288K
Net increase
(decrease) in cash and cash...
$695K
Canceled cashflow
$1,099K
Payments of offering
costs relating to...
$288K
Loss on january 2026
inducement offer
-$2,877K
Unrealized loss subsequent
to receipt of above...
-$1,538K
Issuance and offering
costs
$421K
Inventories
-$372K
Operating lease
liabilities
$139K
Stock-based compensation
$15K
Depreciation
$8K
Net cash used in
operating activities
-$1,099K
Canceled cashflow
$5,370K
Net income (loss)
-$4,385K
Change in fair value of
common stock warrant...
$1,191K
Accounts payable and
accrued expenses
-$719K
something is missing
-$139K
Prepaid expenses and
other current assets
$28K
Other current
liabilities
-$7K
Back
Back
Cash Flow
Arcadia Biosciences, Inc. (RKDA)
Arcadia Biosciences, Inc. (RKDA)
source: myfinsight.com